Saudi Arabia IUDs Market Overview, 2031

In Saudi Arabia, the contraceptive landscape has gradually shifted toward methods that offer long-term reliability and minimal daily maintenance, with intrauterine devices gaining increasing attention. Both hormonal and copper IUDs are widely available, providing women with options that suit their health needs, fertility goals, and personal preferences. Awareness about reproductive health has improved, supported by public health initiatives and recommendations from healthcare practitioners, making these devices more commonly considered for birth spacing and menstrual management. Advancements in design, materials, and insertion techniques have enhanced comfort, safety, and acceptability, while the coexistence of hormonal and non-hormonal options allows tailored choices. Growing urbanization, rising disposable incomes, and increased participation of women in education and the workforce have reinforced the appeal of convenient, long-acting contraceptives. Regulatory oversight by the Saudi Food and Drug Authority ensures that devices meet quality and safety standards, complementing government programs that expand access across urban and rural healthcare settings. Adoption patterns are influenced by factors such as age, parity, income, education, and urban residency, while cultural sensitivities, misconceptions about side effects, limited provider availability in some areas, and cost considerations can affect uptake. The local IUD segment forms part of a broader regional trend in the Middle East toward long-acting reversible contraceptives, with Saudi Arabia emerging as a key contributor due to supportive healthcare infrastructure and public health focus, where intrauterine devices now rank among the most commonly used methods after oral contraceptives, reflecting steady growth in awareness and adoption across diverse population segments.

According to the research report, "Saudi Arabia IUDs Overview, 2031," published by Bonafide Research, the Saudi Arabia IUDs is anticipated to grow at more than 7% CAGR from 2026 to 2031.Saudi Arabia hosts a mix of local and international players in the contraceptive device sector, with companies like SPIMACO operating as vertically integrated pharmaceutical and medical-appliance manufacturers, though specialized device production remains limited and imports continue to dominate. Global firms such as SMB Corporation of India supply copper-based and copper-alloy IUDs, often accompanied by insertion instruments, while Bayer, CooperSurgical, Teva, and AbbVie also maintain a presence through regional distribution. Products typically include copper and hormonal IUDs along with disposable insertion equipment, and distribution relies heavily on hospitals, clinics, and authorized representatives who manage regulatory registration, quality compliance, and post-market surveillance. Local pharmaceutical firms have the potential to expand into device manufacturing, but the current focus is mainly on generics. Government procurement and public health initiatives offer avenues for supplying devices to hospitals and maternal health programs, particularly if local production is incentivized. Regulatory oversight by the SFDA requires device registration, quality management aligned with ISO 13485:2016, Unique Device Identification for traceability, and ongoing post-market reporting. Cultural and social sensitivities, high import costs, and complex regulatory requirements create barriers for new entrants, while alternative contraceptives such as oral pills, injectables, implants, condoms, and sterilization provide competition. Affordability considerations include both the device price and medical procedure costs, and local manufacturing could enhance supply reliability and reduce costs, influencing adoption and market dynamics.

In Saudi Arabia, women seeking long-term contraception often choose between two main intrauterine device types recognized by national health authorities: copper IUDs and hormonal progestin-releasing IUDs. Hormonal devices have gradually attracted attention due to their ability to reduce menstrual bleeding and cramps while providing reversible contraception over several years, appealing especially to women desiring hormone-based options with additional menstrual benefits. Many of these devices allow use for three to five years depending on the brand, and some evidence suggests longer durations under medical supervision. Copper IUDs maintain steady popularity, favored by women wishing to avoid systemic hormones, offering a cost-effective, long-lasting solution that can remain in place for up to a decade and is widely considered safe. Potential demand exists for more advanced options, such as frameless, biodegradable, or flexible IUDs, which promise greater comfort or reduced foreign-body exposure, but regulatory hurdles, limited provider familiarity, and absence from public health guidelines currently restrict their presence in the Saudi market. Regulatory oversight treats copper IUDs as medical devices and hormonal IUDs as medicinal products, influencing approval pathways, pharmacovigilance requirements, and market entry considerations. Uptake is shaped by healthcare infrastructure, urban access to gynecological services, and growing awareness of long-acting reversible contraception, while cultural attitudes, misconceptions regarding infection or ectopic pregnancy risk, and cost considerations affect individual choices. Women weigh convenience, reversibility, and non-contraceptive benefits when selecting a device, and overall market behavior reflects diverse preferences, with both segments supported by family-planning programs, improved clinical access, and gradual acceptance of long-term contraceptive methods across different populations.

Women seeking long-term contraception often choose facilities based on accessibility, privacy, and quality of care. Hospitals typically handle the largest share of insertions due to their procedural infrastructure, specialist availability, sterilization capabilities, and ability to manage complications, while providing postpartum or post-abortion services and comprehensive follow-up. Gynecology and specialized reproductive clinics offer personalized consultations, shorter waiting times, and a women-centric environment, attracting those who prefer outpatient care or more discretion. Family-planning centers serve populations seeking education-oriented counseling and subsidized services, though in some Saudi regions their absence limits uptake and access, particularly for women interested in spacing births or avoiding hormonal methods. Community health centers provide access in rural or underserved areas, yet gaps in specialized staff, training, and follow-up resources can constrain service delivery and trust, even as they represent potential for broader outreach. Private practice clinics appeal to those valuing convenience, privacy, or faster service, but higher costs and variable integration with public health systems may limit use. Academic medical centers contribute both service and training, shaping provider capacity and influencing long-term adoption, though inconsistent exposure during residency can affect clinician confidence in recommending IUDs. Facilities offering procedural safety, trained personnel, and follow-up support attract women seeking reliable care, while convenience, discretion, and personalized consultation drive demand at clinics and private practices. Patterns in Saudi surveys show IUDs as a significant contraceptive choice, particularly in hospital-linked outpatient and primary-care settings, yet limited availability of family-planning services, low awareness of non-contraceptive benefits, and misconceptions about risks remain notable barriers to broader adoption.

In Saudi Arabia, the distribution of IUDs involves multiple channels that cater to diverse healthcare settings and patient needs. Large hospitals and gynecology clinics often maintain direct relationships with multinational suppliers such as Bayer and CooperSurgical, enabling training, inventory management, and regulatory compliance support while ensuring product authenticity. Hospital pharmacies serve as central points for both hormonal and copper IUDs, facilitating proper storage, tracking, and in-house access for gynecology departments and outpatient services. Smaller clinics and private practitioners rely on retail pharmacies, which provide easier access, urban coverage, and pharmacist-led counseling, though prescriptions and medical supervision remain necessary for certain devices. Online platforms are gradually emerging, particularly in urban areas, offering convenience and privacy, but regulatory scrutiny and procedural requirements limit direct-to-consumer adoption. Distributors bridge the gap between manufacturers and dispersed healthcare facilities, managing logistics, cold-chain requirements, and consolidated billing, which supports timely access to smaller hospitals and clinics. Government procurement channels, coordinated through the Ministry of Health, supply public hospitals, primary-care centers, and family-planning clinics with subsidized or free devices, reinforcing accessibility across socio-economic segments while operating within tender-based systems and regulatory standards. Hospitals and academic centers generally favor direct sales or hospital pharmacies, private gynecology clinics utilize distributors and retail channels, and community or primary-care centers depend largely on government procurement and distributor networks, reflecting a landscape shaped by healthcare infrastructure expansion, regulatory oversight, and evolving patient preferences.



Considered in this report
• Historic year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Saudi Arabia IUDs Market with its value and forecast along with its segments
• IUDs Market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Hormonal IUDs
• Copper IUDs
• Other IUD Types
• Combination Systems
• Biodegradable IUDs
• Advanced Material IUDs

By End-User
• Hospitals
• Gynecology Clinics
• Family Planning Centers
• Community Health Centers
• Private Practice Clinics
• Academic Medical Centers

By Distribution Channel
• Direct Sales
• Hospital Pharmacies
• Retail Pharmacies
• Online Platforms
• Healthcare Distributors
• Government Procurement